Close-up of a scientist holding a tray of petri dishes with purple cultures, wearing gloves and safety gear.

About us

Born from the collective ambition of industry veterans and technology innovators, our mission is to expedite the journey of groundbreaking healthcare solutions from conception to global markets.

$500m+

Funding secured for product development projects

$500m+

Funding secured for product development projects

$500m+

Funding secured for product development projects

30+

Life-changing products launched

30+

Life-changing products launched

30+

Life-changing products launched

* Add any required disclaimer text for the claims made above using this small fine-print text.

Smiling man wearing glasses and a pink shirt, showing his arm with a bandage after vaccination.

OUR SERVICES

Meet our team

Clarent covers full rentention lifecycle, from diagnosis to ongoing operations

OUR SERVICES

Meet our team

Clarent covers full rentention lifecycle, from diagnosis to ongoing operations

OUR SERVICES

Meet our team

Clarent covers full rentention lifecycle, from diagnosis to ongoing operations

Leadership

David Kahn

Chief Executive Officer

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

David Kahn

Chief Executive Officer

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

David Kahn

Chief Executive Officer

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

Victoria Ruiz

Chief Financial Officer

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

Victoria Ruiz

Chief Financial Officer

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

Victoria Ruiz

Chief Financial Officer

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

Agents

Luke Connors

Head of Product

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

Luke Connors

Head of Product

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

Luke Connors

Head of Product

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

Caitlyn Kirby

Product Manager

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

Caitlyn Kirby

Product Manager

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

Caitlyn Kirby

Product Manager

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

Graham Vioski

Head of Development

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

Graham Vioski

Head of Development

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

Graham Vioski

Head of Development

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

Bella Ridley

Key Accounts Manager

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

Bella Ridley

Key Accounts Manager

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

Bella Ridley

Key Accounts Manager

Co-founder, Data Science and ML 17+ years delivering predictive models and advanced analytics for large enterprises across logistics, telco, and fintech. Previously led the data and analytics function at amaysim during its growth from startup to 700,000+ customers.

OUR SERVICES

Our Process

Clarent covers full rentention lifecycle, from diagnosis to ongoing operations

OUR SERVICES

Our Process

Clarent covers full rentention lifecycle, from diagnosis to ongoing operations

OUR SERVICES

Our Process

Clarent covers full rentention lifecycle, from diagnosis to ongoing operations

01

Discovery and Assessment

The journey begins with proactive search for promising medical research projects. Our team conducts a thorough assessment, evaluating each project's innovation, potential impact, and feasibility. This involves rigorous scientific review, potential market analysis, and preliminary discussions with research teams to understand their vision, capabilities, and needs.

01

Discovery and Assessment

The journey begins with proactive search for promising medical research projects. Our team conducts a thorough assessment, evaluating each project's innovation, potential impact, and feasibility. This involves rigorous scientific review, potential market analysis, and preliminary discussions with research teams to understand their vision, capabilities, and needs.

01

Discovery and Assessment

The journey begins with proactive search for promising medical research projects. Our team conducts a thorough assessment, evaluating each project's innovation, potential impact, and feasibility. This involves rigorous scientific review, potential market analysis, and preliminary discussions with research teams to understand their vision, capabilities, and needs.

02

Due Diligence and Selection

Following initial assessments, selected projects undergo a comprehensive  due diligence process. This step digs deeper into the project's  technical details, team qualifications, legal considerations, and  financial requirements. It ensures that only the most viable and  impactful projects are chosen for funding, aligning with Stem's mission  to accelerate the development of transformative healthcare solutions.

02

Due Diligence and Selection

Following initial assessments, selected projects undergo a comprehensive  due diligence process. This step digs deeper into the project's  technical details, team qualifications, legal considerations, and  financial requirements. It ensures that only the most viable and  impactful projects are chosen for funding, aligning with Stem's mission  to accelerate the development of transformative healthcare solutions.

02

Due Diligence and Selection

Following initial assessments, selected projects undergo a comprehensive  due diligence process. This step digs deeper into the project's  technical details, team qualifications, legal considerations, and  financial requirements. It ensures that only the most viable and  impactful projects are chosen for funding, aligning with Stem's mission  to accelerate the development of transformative healthcare solutions.

03

Matching with Investors

Once a project passes our stringent evaluation process, Stem matches it  with suitable investors from our network. This matchmaking is based on  the project's specific needs and the investor's interest areas and  investment philosophy. Our aim is to create synergistic partnerships  that provide not just financial support but also strategic value to  propel the research forward.

03

Matching with Investors

Once a project passes our stringent evaluation process, Stem matches it  with suitable investors from our network. This matchmaking is based on  the project's specific needs and the investor's interest areas and  investment philosophy. Our aim is to create synergistic partnerships  that provide not just financial support but also strategic value to  propel the research forward.

03

Matching with Investors

Once a project passes our stringent evaluation process, Stem matches it  with suitable investors from our network. This matchmaking is based on  the project's specific needs and the investor's interest areas and  investment philosophy. Our aim is to create synergistic partnerships  that provide not just financial support but also strategic value to  propel the research forward.

OUR SERVICES

Latest News

Clarent covers full rentention lifecycle, from diagnosis to ongoing operations

OUR SERVICES

Latest News

Clarent covers full rentention lifecycle, from diagnosis to ongoing operations

OUR SERVICES

Latest News

Clarent covers full rentention lifecycle, from diagnosis to ongoing operations

Level 2/11 York St,
Sydney NSW 2000
Australia

The Penthouse
Level 2/28 Helwick Street
Wanaka 9305,
New Zealand

The Bowenvale Group Pty Ltd, trading as Clarent Pty Ltd. ABN 19 621 552 994. All rights reserved.

Level 2/11 York St,
Sydney NSW 2000
Australia

The Penthouse
Level 2/28 Helwick Street
Wanaka 9305,
New Zealand

The Bowenvale Group Pty Ltd, trading as Clarent Pty Ltd. ABN 19 621 552 994. All rights reserved.

Level 2/11 York St,
Sydney NSW 2000
Australia

The Penthouse
Level 2/28 Helwick Street
Wanaka 9305,
New Zealand

The Bowenvale Group Pty Ltd, trading as Clarent Pty Ltd. ABN 19 621 552 994. All rights reserved.

Create a free website with Framer, the website builder loved by startups, designers and agencies.